Amgen Set to Present at 2026 Wells Fargo Healthcare Conference
Amgen, a biotechnology company listed on the NASDAQ under the ticker AMGN, announced that it will present at the 2026 Wells Fargo Healthcare Conference. The conference is scheduled to take place on Thursday, September 10, 2026, at 11:00 a.m. ET. Thomas Dittrich, executive vice president and chief financial officer of Amgen, along with Paul Burton, M.D., Ph.D, senior vice president and chief medical officer, and Kave Niksefat, senior vice president of Global Marketing and Access, will present at the conference.
The presentation will be broadcast over the internet simultaneously and will be available to members of the news media, investors, and the general public. This is an opportunity for Amgen to showcase its recent developments and provide updates on its business strategy.